We begin with a thorough scientific and commercial due diligence of novel technologies. We collaborate with inventors to determine the best management and ownership structure.
At every turn, we’re assessing opportunity and fit.
Once selected, we negotiate licensing the technology into the studio. The studio's primary goal is to de-risk novel technologies, both scientifically and commercially.
We bring deep experience to define business strategy, identify key partners, and optimize the path to regulatory approval and commercialization.
As technologies are being de-risked and validated, we form a dedicated startup and recruit a founding team.
At this stage, seed funding is raised to support continued development.
We continue to support all portfolio companies while they raise additional capital and continue pre-clinical and clinical development.
We guide our portfolio companies toward the most favorable next step in their journey, be it acquisition or strategic partnership.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.